Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research

Nanotechnology Platform Partnerships Pre-Application Meeting

On July 23, 2009, NCI held a pre-application meeting for prospective applicants interested in applying for grants under the NCI Alliance for Nanotechnology in Cancer funding opportunity RFA-CA-09-013 (Cancer Nanotechnology Platform Partnerships).

NCI program and review staff members explained the goals and objectives of the Alliance program components, conducted a discussion on the application peer review process and facilitated a Q&A session. The meeting presentations are available below.

View the NIH videocast of the full meeting and Q&A session.

View RFA-CA-09-013

Meeting Presentations

Dr. Anna Barker, Deputy Director of NCI, highlighted the challenges and opportunities facing cancer nanotechnology researchers today. View Dr. Barker's presentation

Dr. Piotr Grodzinski, Director of the Alliance, explained the goals of the Cancer Nanotechnology Platform Partnerships program and the application process. View Dr. Grodzinski's presentation

Dr. Savvos Makrides, a Scientific Review Officer at NCI, outlined the review process for the Cancer Nanotechnology Platform Partnerships grant applications. View Dr. Makrides's presentation

Ms. Emily Linde from the Office of Grants Administration detailed Cancer Nanotechnology Platform Partnerships grant administration policies at NCI. View Ms. Linde's presentation

Frequently Asked Questions

For answers to the most frequently asked questions regarding the CCNE U54 application please visit "Frequently Asked Questions".